Free Trial

Plexus Corp. (NASDAQ:PLXS) CEO Todd P. Kelsey Sells 2,000 Shares

Plexus logo with Computer and Technology background

Plexus Corp. (NASDAQ:PLXS - Get Free Report) CEO Todd P. Kelsey sold 2,000 shares of the business's stock in a transaction that occurred on Tuesday, May 27th. The stock was sold at an average price of $131.68, for a total transaction of $263,360.00. Following the sale, the chief executive officer now directly owns 76,714 shares of the company's stock, valued at approximately $10,101,699.52. This trade represents a 2.54% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website.

Plexus Stock Down 0.8%

Shares of PLXS stock traded down $1.01 during trading hours on Friday, hitting $130.72. 200,701 shares of the company were exchanged, compared to its average volume of 168,818. The business has a 50 day moving average of $125.79 and a two-hundred day moving average of $141.15. The company has a current ratio of 1.53, a quick ratio of 0.70 and a debt-to-equity ratio of 0.07. Plexus Corp. has a 52 week low of $100.96 and a 52 week high of $172.89. The company has a market capitalization of $3.54 billion, a PE ratio of 30.33 and a beta of 0.80.

Plexus (NASDAQ:PLXS - Get Free Report) last issued its quarterly earnings data on Wednesday, April 23rd. The technology company reported $1.66 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.54 by $0.12. The company had revenue of $980.17 million during the quarter, compared to the consensus estimate of $980.07 million. Plexus had a net margin of 3.03% and a return on equity of 10.36%. The firm's revenue was up 1.4% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $0.94 earnings per share. Analysts anticipate that Plexus Corp. will post 5.9 earnings per share for the current fiscal year.

Analysts Set New Price Targets

Several research firms have weighed in on PLXS. Stifel Nicolaus set a $145.00 target price on shares of Plexus in a report on Thursday, April 24th. Benchmark reiterated a "buy" rating and issued a $160.00 target price on shares of Plexus in a report on Friday, May 16th. Finally, Needham & Company LLC reiterated a "buy" rating and issued a $162.00 target price (down from $172.00) on shares of Plexus in a report on Friday, April 25th. Two research analysts have rated the stock with a hold rating and three have assigned a buy rating to the company's stock. According to data from MarketBeat, the company has an average rating of "Moderate Buy" and a consensus target price of $155.67.

View Our Latest Analysis on PLXS

Institutional Inflows and Outflows

A number of hedge funds have recently added to or reduced their stakes in PLXS. TD Private Client Wealth LLC bought a new position in Plexus in the fourth quarter valued at $28,000. Aquatic Capital Management LLC grew its position in Plexus by 134.0% in the fourth quarter. Aquatic Capital Management LLC now owns 234 shares of the technology company's stock valued at $37,000 after purchasing an additional 134 shares in the last quarter. R Squared Ltd bought a new position in Plexus in the fourth quarter valued at $45,000. Nomura Asset Management Co. Ltd. grew its position in Plexus by 45.5% in the fourth quarter. Nomura Asset Management Co. Ltd. now owns 320 shares of the technology company's stock valued at $50,000 after purchasing an additional 100 shares in the last quarter. Finally, Versant Capital Management Inc grew its position in Plexus by 1,000.0% in the first quarter. Versant Capital Management Inc now owns 473 shares of the technology company's stock valued at $61,000 after purchasing an additional 430 shares in the last quarter. Institutional investors own 94.45% of the company's stock.

Plexus Company Profile

(Get Free Report)

Plexus Corp. provides electronic manufacturing services in the United States and internationally. It offers design, develop, supply chain, new product introduction, and manufacturing solutions, as well as sustaining services to companies in the healthcare/life sciences, industrial/commercial, aerospace/defense, and communications market sectors.

Read More

Insider Buying and Selling by Quarter for Plexus (NASDAQ:PLXS)

Should You Invest $1,000 in Plexus Right Now?

Before you consider Plexus, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Plexus wasn't on the list.

While Plexus currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Ten Starter Stocks For Beginners to Buy Now Cover

Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Congress Is Pouring Millions Into These 6 Surprising Stocks
3 Dirt-Cheap Stocks in a Market That’s Getting Expensive
Top 3 Defense Stocks to Profit From $175 Billion Golden Dome

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines